<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26891" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Penicillin</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yip</surname>
            <given-names>Derek W.</given-names>
          </name>
          <aff>California Northstate University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gerriets</surname>
            <given-names>Valerie</given-names>
          </name>
          <aff>California Northstate University College of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Derek Yip declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Valerie Gerriets declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>20</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26891.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p content-type="pubmed-excerpt">Penicillin is one of the most commonly used broad-spectrum antibiotics globally and has numerous clinical indications.&#x000a0;Penicillin is effective against infections caused by gram-positive cocci, gram-positive rods, most anaerobes, and gram-negative cocci, and it stands as a cornerstone in the management and treatment of various infections within the &#x003b2;-lactam antibiotic class of drugs.&#x000a0;Most bacteria feature a peptidoglycan cell wall encasing the bacterial plasma membrane, which&#x000a0;prevents&#x000a0;osmotic lysis and offers structural stability. This peptidoglycan wall undergoes continuous remodeling during replication and growth. Penicillin functions by inhibiting&#x000a0;the cross-linking of peptidoglycan within the cell wall.</p>
        <p>Given the rise of resistance, penicillin should be reserved solely for susceptible organisms. This activity&#x000a0;encompasses the delineation of penicillin's indications, mechanism of action, administration, adverse event profile, pharmacokinetics, monitoring, and pertinent interactions essential for interprofessional healthcare team members in infection treatment.&#x000a0;This activity enhances the clinical team's comprehension of promptly evaluating and administering the appropriate antibiotic for treating several infections, thereby improving patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the appropriate indications for penicillin therapy based on the specific microbial etiology and clinical presentation.</p></list-item><list-item><p>Implement evidence-based guidelines for the safe and effective administration of penicillin, considering patient-specific factors such as age, renal function, and comorbidities.</p></list-item><list-item><p>Select alternative antibiotic therapies in cases of penicillin allergy or resistance, considering the spectrum of activity and susceptibility testing results.</p></list-item><list-item><p>Coordinate with microbiology and infectious disease specialists to optimize penicillin therapy for complex or resistant infections, utilizing their expertise in antimicrobial management to optimize penicillin therapy.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26891&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26891">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26891.s2" sec-type="Indications">
        <title>Indications</title>
        <p>Penicillin is one of the most commonly used broad-spectrum antibiotics globally and has numerous clinical indications.&#x000a0;Penicillin is effective against infections caused by gram-positive cocci, gram-positive rods, most anaerobes, and gram-negative cocci.<xref ref-type="bibr" rid="article-26891.r1">[1]</xref>&#x000a0;Penicillin&#x000a0;stands as a cornerstone in the management and treatment of various infections within the &#x003b2;-lactam antibiotic class of drugs.&#x000a0;</p>
        <p>Notably, certain bacterial species have&#x000a0;developed penicillin resistance, including enterococci. Therefore, due to emerging resistance, penicillin should only be used for susceptible organisms. Enterococci infections&#x000a0;are now treated&#x000a0;with penicillin, streptomycin, or gentamicin.<xref ref-type="bibr" rid="article-26891.r2">[2]</xref>&#x000a0;Specific gram-negative rods are also resistant&#x000a0;to penicillin due to penicillin&#x02019;s poor ability to penetrate the porin channel.<xref ref-type="bibr" rid="article-26891.r3">[3]</xref>&#x000a0;</p>
        <p>However, later generations of broad-spectrum penicillins are effective against gram-negative rods. Second-generation penicillins, such as ampicillin and amoxicillin, can penetrate the porin channel, making these drugs effective against <italic toggle="yes">Proteus mirabilis</italic>, <italic toggle="yes">Shigella</italic>,&#x000a0;&#x000a0;<italic toggle="yes">Haemophilus influenzae</italic>, <italic toggle="yes">Salmonella</italic>, and <italic toggle="yes">Escherichia&#x000a0;coli</italic>. Third-generation penicillin, such as carbenicillin, can penetrate gram-negative bacterial porin channels. Fourth-generation penicillins such as piperacillin are effective against the same bacterial strains as third-generation penicillins&#x000a0;and&#x000a0;<italic toggle="yes">Klebsiella</italic>, enterococci, <italic toggle="yes">Pseudomonas aeruginosa</italic>, and <italic toggle="yes">Bacteroides fragilis</italic>.<xref ref-type="bibr" rid="article-26891.r4">[4]</xref>&#x000a0;</p>
        <p>
<bold>FDA-Approved Indications</bold>
</p>
        <p>
<bold>Penicillin G:&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Anthrax caused by&#x000a0;<italic toggle="yes">Bacillus anthracis</italic></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Actinomycosis caused by&#x000a0;<italic toggle="yes">Actinomyces israelii</italic></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Clostridium</italic> infection in conjugation with&#x000a0;antitoxin</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Diptheria caused by&#x000a0;<italic toggle="yes">Corynebacterium diphtheria&#x000a0;</italic>with<italic toggle="yes">&#x000a0;</italic>antitoxin</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Fusospirochetosis caused by&#x000a0;<italic toggle="yes">Fusobacterium</italic>&#x000a0;species and spirochetes</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Endocarditis caused by sensitive&#x000a0;<italic toggle="yes">Streptococcus pyogenes</italic>&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Rat bite fever caused by&#x000a0;<italic toggle="yes">Spirillum minus</italic>&#x000a0;or&#x000a0;<italic toggle="yes">Streptobacillus moniliformis</italic>&#x000a0;<xref ref-type="bibr" rid="article-26891.r5">[5]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Tetanus caused by&#x000a0;<italic toggle="yes">Clostridium tetani</italic> with immune globulin and vaccine administration</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Meningitis caused by&#x000a0;<italic toggle="yes">Listeria monocytogenes</italic>,&#x000a0;&#x000a0;<italic toggle="yes">Meningococcus</italic>,&#x000a0;and <italic toggle="yes">Streptococcus</italic>&#x000a0;<xref ref-type="bibr" rid="article-26891.r6">[6]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Neurosyphilis caused by&#x000a0;<italic toggle="yes">Treponema pallidum</italic>&#x000a0;<xref ref-type="bibr" rid="article-26891.r7">[7]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Penicillin V:&#x000a0;</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Mild-to-moderate infections of the upper respiratory tract infection caused by <italic toggle="yes">Streptococcus</italic> and <italic toggle="yes">Pneumococcus</italic></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Scarlet&#x000a0;fever and erysipelas (mild) caused by&#x000a0;group A <italic toggle="yes">Streptococcus</italic></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Gingivitis caused by <italic toggle="yes">Bacillus&#x000a0;fusiformis</italic> and <italic toggle="yes">Borrelia vincentii</italic>&#x000a0;(along with appropriate dental care)&#x000a0;<xref ref-type="bibr" rid="article-26891.r8">[8]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Benzathine Penicillin:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Preventing rheumatic fever <xref ref-type="bibr" rid="article-26891.r9">[9]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Treating syphilis (primary, secondary, and latent)&#x000a0;<xref ref-type="bibr" rid="article-26891.r10">[10]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26891.s3" sec-type="Mechanism of Action">
        <title>Mechanism of Action</title>
        <p>Most bacteria feature a peptidoglycan cell wall encasing the bacterial plasma membrane, which&#x000a0;prevents&#x000a0;osmotic lysis and offers structural integrity. This peptidoglycan wall undergoes continuous remodeling during replication and growth. Penicillin functions by inhibiting&#x000a0;the cross-linking of peptidoglycan within the cell wall.<xref ref-type="bibr" rid="article-26891.r11">[11]</xref>&#x000a0;</p>
        <p>The catalyst for this reaction is&#x000a0;penicillin-binding proteins, such as the enzyme DD-transpeptidase. Penicillin's 4-membered &#x003b2;-lactam ring can bind to DD-transpeptidase to irreversibly inactive it. The bacteria cannot build their cell walls while other&#x000a0;proteins break down the wall.<xref ref-type="bibr" rid="article-26891.r12">[12]</xref>&#x000a0;</p>
        <p>As the bacteria's cell wall continues to weaken, osmotic pressure pushes water into the cell and kills the cell. Peptidoglycan fragments further destroy the cell wall as these fragments can activate autolysins and hydrolases. Penicillin&#x000a0;is combined&#x000a0;with a &#x003b2;-lactamase inhibitor such as clavulanic acid to enhance the bactericidal effect. &#x003b2;-lactamase inhibitors prevent the degradation of the &#x003b2;-lactam ring in penicillin, which can occur when certain bacteria express the enzyme &#x003b2;-lactamase.<xref ref-type="bibr" rid="article-26891.r13">[13]</xref></p>
        <p>
<bold>Pharmacokinetics</bold>
</p>
        <p><bold>Absorption:</bold>&#x000a0;The potassium salt of penicillin V (oral formulation) is&#x000a0;resistant to inactivation by gastric acid; however, penicillin G is destroyed by stomach acid. Benzathine penicillin G has slow hydrolysis and absorption, resulting in a prolonged half-life.</p>
        <p><bold>Distribution: </bold>Penicillin V and penicillin G have approximately 80% and 60% plasma protein binding, respectively. Tissue levels are highest in the kidneys. The concentration&#x000a0;of penicillin in abscesses, synovial, and peritoneal fluids is higher in the presence of inflammation. However, penicillin G does&#x000a0;have poor distribution in polymorphonuclear leukocytes.&#x000a0;</p>
        <p><bold>Metabolism:</bold> Penicillin derivatives are minimally metabolized by the liver. Organic anion transporter-3 plays a vital role in renal excretion.<xref ref-type="bibr" rid="article-26891.r14">[14]</xref></p>
        <p><bold>Elimination: </bold>These agents are rapidly excreted in the urine as they are water-soluble, and others are excreted in bile. Penicillin&#x000a0;has a relatively short half-life of about 2 hours. Penicillin is excreted rapidly by tubular excretion, which is inhibited by probenecid.<xref ref-type="bibr" rid="article-26891.r15">[15]</xref><xref ref-type="bibr" rid="article-26891.r16">[16]</xref><xref ref-type="bibr" rid="article-26891.r17">[17]</xref></p>
      </sec>
      <sec id="article-26891.s4" sec-type="Administration">
        <title>Administration</title>
        <p>
<bold>Available Dosage Forms, Strengths, and Dosages</bold>
</p>
        <p>Penicillin G can be administrated by intravenous (IV) or intramuscular (IM) route. Penicillin G potassium for injection USP vial is available in&#x000a0;1 million units, 5 million units, and 20 million units per vial. Because of the short half-life, penicillin G is usually administered in divided doses 4 to 6 hours apart via the IV or IM route.&#x000a0;Penicillin G benzathine administration ensures a continuous low dose of penicillin G over 2 to 4 weeks.&#x000a0;FDA has also approved a procaine penicillin G combination of antibiotics and local anesthetics.<xref ref-type="bibr" rid="article-26891.r7">[7]</xref></p>
        <p>Penicillin V and its potassium salt derivative, penicillin VK, are accessible in orally administered forms, including solutions for reconstitution (125 mg/5 mL and 250 mg/5 mL) and tablets (250 mg and 500 mg).<xref ref-type="bibr" rid="article-26891.r18">[18]</xref>&#x000a0;Penicillin V is best administered to a fasting patient as it degrades in stomach acid. Based on the clinical indication and patient weight, the usual dosage ranges from 125 to 500 mg every 6 to 8 hours.</p>
        <p>As with any antibiotic, patients&#x000a0;should be advised to finish the treatment course to prevent bacterial resistance. Penicillin demonstrates limited crossing of the blood-brain barrier. According to the Infectious Diseases Society of America (IDSA), penicillin G is recommended for bacterial meningitis caused by susceptible organisms such as&#x000a0;Propionibacterium acnes<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-26891.r19">[19]</xref>&#x000a0;According to the Centers for Disease Control and Prevention (CDC), penicillin should not be used as first-line therapy for treatment or postexposure prophylaxis for anthrax until susceptibility results.<xref ref-type="bibr" rid="article-26891.r20">[20]</xref></p>
        <p>
<bold>Specific Patient Populations</bold>
</p>
        <p><bold>Hepatic impairment:</bold> Hepatic impairment warrants caution, particularly in cirrhosis cases, due to hypoalbuminemia.<xref ref-type="bibr" rid="article-26891.r21">[21]</xref></p>
        <p><bold>Renal impairment:&#x000a0;</bold>Although renal impairment is not a contraindication for penicillin, doses must be adjusted given end-stage renal disease. Depending on the glomerular filtration rate, these patients will receive a full loading dose and half a loading dose every 8&#x000a0;to 10 or 4&#x000a0;to 5 hours.<xref ref-type="bibr" rid="article-26891.r22">[22]</xref></p>
        <p><bold>Pregnancy considerations:</bold> Penicillin G belongs to the FDA pregnancy category B drug. No severe adverse events are observed with penicillin G.&#x000a0;Eliminating penicillin V is increased during pregnancy, requiring dose adjustment with an increased dose of the standard dosing interval or shorter dosing intervals of the standard dose. According to the American College of Obstetricians and Gynecologists (ACOG) guidelines, penicillin G is recommended for group B <italic toggle="yes">Streptococcus</italic> (GBS) prophylaxis. The recommendation is a loading dose of&#x000a0;5 million units followed by 2.5 to 3 million units every 4 hours till delivery.<xref ref-type="bibr" rid="article-26891.r23">[23]</xref><xref ref-type="bibr" rid="article-26891.r24">[24]</xref></p>
        <p><bold>Breastfeeding considerations:</bold>&#x000a0;According to the literature, penicillin G and penicillin V&#x000a0;are found in milk at low levels that are unexpected to cause adverse reactions in breastfed infants.&#x000a0;Some research has reported that penicillin can disrupt the infant's gastrointestinal flora, causing diarrhea or thrush; however, these&#x000a0;adverse&#x000a0;effects have not been adequately evaluated. The use of penicillin G or penicillin V is acceptable for nursing mothers.<xref ref-type="bibr" rid="article-26891.r25">[25]</xref><xref ref-type="bibr" rid="article-26891.r26">[26]</xref></p>
        <p><bold>Pediatric patients:&#x000a0;</bold>The pediatric dose of penicillin is calculated based on the body surface area and weight. The CDC recommends Benzathine penicillin G&#x000a0;50,000 units/kg IM, up to 2.4 million units in a single dose for treating primary and secondary syphilis.<xref ref-type="bibr" rid="article-26891.r10">[10]</xref></p>
        <p><bold>Older patients: </bold>Older patients should exercise caution when using due to the potential for reduced glomerular filtration rate.<xref ref-type="bibr" rid="article-26891.r27">[27]</xref></p>
      </sec>
      <sec id="article-26891.s5" sec-type="Adverse Effects">
        <title>Adverse Effects</title>
        <p>Penicillin V and G can have adverse effects, including nausea, vomiting, diarrhea, rash, abdominal pain, and urticaria. In addition, Penicillin G can have other adverse reactions, including muscle spasms, fever, chills, muscle pain, headache, tachycardia, flushing, tachypnea, and hypotension.</p>
        <p><bold>Hypersensitivity reactions:&#x000a0;</bold>The commonly encountered adverse drug reaction with penicillin is hypersensitivity of immediate onset or delayed onset.</p>
        <list list-type="bullet">
          <list-item>
            <p>Immediate onset: This type of reaction occurs within 20 minutes after administering&#x000a0;the drug and is characterized by urticaria, pruritis, edema, laryngospasm, bronchospasm, hypotension, vascular collapse, and death.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Delayed onset: This type of reaction occurs within 1 to 2 weeks of treatment, is rare, and is characterized by fever, malaise, urticaria, myalgia, arthralgia, abdominal pain, and skin rashes.<xref ref-type="bibr" rid="article-26891.r28">[28]</xref></p>
          </list-item>
        </list>
        <p><bold>Gastrointestinal system:</bold> Gastrointestinal symptoms, including nausea, vomiting, and stomatitis, were the most commonly reported in over 1% of patients and widely observed with oral administration. Pseudomembranous colitis is also observed during or after the treatment.</p>
        <p><bold>Hematologic reactions:</bold> If the dose exceeds 10 million units per day and a patient has received a higher dose previously, then those patients can precipitate Coombs-positive hemolytic anemia and neutropenia, resolved when therapy is stopped.</p>
        <p><bold>Metabolic reactions:</bold> The salt form of penicillin G may cause electrolyte imbalances, such as hyperkalemia, when given IV in a large dose.</p>
        <p><bold>Nervous system:</bold> Neurological manifestations include hyperreflexia, myoclonic cramps, seizures, and coma after IV doses and are more likely in patients with impaired renal function.<xref ref-type="bibr" rid="article-26891.r29">[29]</xref></p>
        <p><bold>Urogenital system:</bold> Urological manifestations with large IV doses include renal tubular damage.&#x000a0;Penicillins can also cause acute interstitial nephritis, a disease characterized by inflammation of the tubules and interstitium of the kidneys.<xref ref-type="bibr" rid="article-26891.r30">[30]</xref>&#x000a0;Acute interstitial nephritis can also present with hematuria, fever, and rash. The recommendation is to withdraw the drug as the disease could lead&#x000a0;to renal failure.&#x000a0;</p>
        <p><bold>Other reactions:&#x000a0;</bold>Jarisch- Herxheimer reaction is precipitated when penicillin is administered in patients with syphilis due to rapid lysis of spirochetes and release of endotoxins.<xref ref-type="bibr" rid="article-26891.r31">[31]</xref>&#x000a0;Procaine reactions (1&#x000a0;in 500 patients) are due to immediate toxic reactions to procaine due to&#x000a0;large single-dose&#x000a0;administration.&#x000a0;Procaine may cause a pseudoanaphylactic reaction.<xref ref-type="bibr" rid="article-26891.r32">[32]</xref>&#x000a0;Procaine can also cause methemoglobinemia.<xref ref-type="bibr" rid="article-26891.r33">[33]</xref>&#x000a0;</p>
        <p>
<bold>Drug-Drug Interactions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Concurrent sulfonamides, erythromycin, and chloramphenicol (bacteriostatic drugs) should be avoided due to antagonistic effects.<xref ref-type="bibr" rid="article-26891.r34">[34]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Tubular secretion of penicillin G&#x000a0;is blocked by probenecid- higher and longer plasma concentrations are achieved. Probenecid also decreases the volume of distribution of penicillin.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Drugs such as aspirin, phenylbutazone, sulfonamides, indomethacin, thiazide, furosemide, and ethacrynic acid increase the half-life of penicillin by competing with tubular secretion.<xref ref-type="bibr" rid="article-26891.r35">[35]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26891.s6" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Contraindications of penicillin include a previous history of severe allergic reactions to penicillin or its derivatives. Penicillin is also contraindicated in patients with a prior history of Stevens-Johnson syndrome after administering penicillin or a penicillin derivative. In addition, penicillin has an antagonistic effect with tetracyclines and can lead to a 2.6 times higher mortality risk when treating pneumococcal meningitis than penicillin alone. However, penicillins are relatively safe to use during pregnancy and lactation.<xref ref-type="bibr" rid="article-26891.r36">[36]</xref>&#x000a0;</p>
        <p>Nearly all antibacterial agents have been linked to <italic toggle="yes">Clostridium difficile&#x02013;</italic>associated diarrhea (CDAD), including penicillin, with severity ranging from mild diarrhea to fatal colitis. Antibacterial agents alter the colon's normal flora, causing the overgrowth of <italic toggle="yes">C difficile</italic>. This strain produces toxins A and B that contribute to the development of CDAD. During infections caused by hypertoxin-producing strains of <italic toggle="yes">C difficile</italic>, the morbidity and mortality rate is&#x000a0;increased since these infections are often resistant to antimicrobial treatments and may require colectomy. Antibiotic treatment is recommended when CDAD is suspected or confirmed. Depending on clinical need, protein supplementation, fluid and electrolyte management, antibiotic treatment, and surgical evaluation&#x000a0;are implemented.<xref ref-type="bibr" rid="article-26891.r37">[37]</xref></p>
      </sec>
      <sec id="article-26891.s7" sec-type="Monitoring">
        <title>Monitoring</title>
        <p>Generally, the monitoring of patients on penicillin is not required. However, one study recommended therapeutic drug monitoring during endocarditis treatment caused by enterococci to determine penicillin exposure and dosing. This vigilance will decrease the chance of antibiotic resistance while improving therapeutic impact.<xref ref-type="bibr" rid="article-26891.r38">[38]</xref>&#x000a0;Prolonged&#x000a0;administration of penicillin requires monitoring hematologic, renal, and hepatic function.</p>
      </sec>
      <sec id="article-26891.s8" sec-type="Toxicity">
        <title>Toxicity</title>
        <p>
<bold>Signs and Symptoms of Overdose</bold>
</p>
        <p>Penicillin&#x000a0;has a small risk of toxicity. Clinicians&#x000a0;can administer penicillin at relatively high doses compared to other drugs without harming patients. Estimates are that it would take 5 g/kg body weight&#x000a0;IV to cause convulsions in a patient. However, penicillin can cause local toxicity due to high-dose injections at sensitive sites such as the eye's anterior chamber or the subarachnoid space. Reports show that pure preparations of penicillin cause no harm to the lungs and veins. Other reports indicate that topical penicillin can prevent coagulation in dental cavities.<xref ref-type="bibr" rid="article-26891.r39">[39]</xref>&#x000a0;</p>
        <p>
<bold>Management&#x000a0;of Overdose</bold>
</p>
        <p>Neurotoxicity of penicillin requires discontinuation of the offending penicillin. Penicillins are&#x000a0;hypothesized&#x000a0;to have an inhibitory effect on GABA transmission; consequently, IV benzodiazepines and electroencephalogram (EEG) monitoring may be necessary in refractory cases.<xref ref-type="bibr" rid="article-26891.r40">[40]</xref></p>
      </sec>
      <sec id="article-26891.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Before prescribing penicillin&#x000a0;to a patient, the prescribing clinician and&#x000a0;consulting team&#x000a0;should confirm that the&#x000a0;underlying infection is likely the result of bacteria sensitive to penicillin. The prescriber, pharmacist, and nurse should also&#x000a0;counsel the patient&#x000a0;on any&#x000a0;adverse drug effects that should prompt a&#x000a0;return visit, such as prolonged diarrhea or severe rash. Clinicians should notify the CDC if the zoonotic disease is suspected, and infectious disease consultation should be obtained.&#x000a0;In an outpatient setting, communication&#x000a0;between the clinician and the pharmacist will allow the drug to be dispensed appropriately to the patient.</p>
        <p>Pharmacists should consult the patient on how best to administer the penicillin and remind them that they should complete the entire course of the antibiotic. This interprofessional approach will optimize therapeutic results while minimizing adverse effects.&#x000a0;A retrospective study concluded that a&#x000a0;team approach between&#x000a0;infectious disease pharmacists with&#x000a0;advanced pharmacy practice experience improves&#x000a0;antimicrobial stewardship interventions.<xref ref-type="bibr" rid="article-26891.r41">[41]</xref></p>
        <p>If a patient has difficulty obtaining drugs for financial or logistical reasons, a social worker may help ensure that the patient receives their medications. In an inpatient setting, communication between the clinician and the nurse will allow the patient to receive the drug. The healthcare team can work together to confirm that the patient has no contraindications to penicillin use.</p>
        <p>If any immediate severe adverse effects occur after administering penicillin, such as anaphylaxis, the&#x000a0;healthcare team should receive notification and treat the acute condition&#x000a0;immediately. A board-certified infectious disease pharmacist can&#x000a0;also consult on the case to confirm if penicillin is the best choice given the patient's diagnosis, current antibiogram data, and any other medications the patient is prescribed.&#x000a0;Furthermore, a flattened hierarchy approach should be in place to ensure that reporting mistakes to a superior can take place without resistance. Utilizing the entire healthcare team is critical to ensure the patient&#x000a0;is comfortable and has the best medical outcome with the lowest chance of complications.&#x000a0;Interprofessional coordination and collaboration among physicians, nurse practitioners, physician assistants, pharmacists, and nurses can improve patient outcomes while using penicillin for treating susceptible infections.</p>
      </sec>
      <sec id="article-26891.s10">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26891&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26891">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26891/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26891">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26891.s11">
        <title>References</title>
        <ref id="article-26891.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friedland</surname>
                <given-names>IR</given-names>
              </name>
              <name>
                <surname>McCracken</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.</article-title>
            <source>N Engl J Med</source>
            <year>1994</year>
            <month>Aug</month>
            <day>11</day>
            <volume>331</volume>
            <issue>6</issue>
            <fpage>377</fpage>
            <page-range>377-82</page-range>
            <pub-id pub-id-type="pmid">8028618</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Herman</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Gerding</surname>
                <given-names>DN</given-names>
              </name>
            </person-group>
            <article-title>Antimicrobial resistance among enterococci.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>1991</year>
            <month>Jan</month>
            <volume>35</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-4</page-range>
            <pub-id pub-id-type="pmid">1901693</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spratt</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Cromie</surname>
                <given-names>KD</given-names>
              </name>
            </person-group>
            <article-title>Penicillin-binding proteins of gram-negative bacteria.</article-title>
            <source>Rev Infect Dis</source>
            <year>1988</year>
            <season>Jul-Aug</season>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>699</fpage>
            <page-range>699-711</page-range>
            <pub-id pub-id-type="pmid">3055170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perry</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Markham</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections.</article-title>
            <source>Drugs</source>
            <year>1999</year>
            <month>May</month>
            <volume>57</volume>
            <issue>5</issue>
            <fpage>805</fpage>
            <page-range>805-43</page-range>
            <pub-id pub-id-type="pmid">10353303</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kache</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Person</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Seeman</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>McQuiston</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>McCollum</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Traxler</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Rat-Bite Fever in the United States: An Analysis Using Multiple National Data Sources, 2001-2015.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>ofaa197</fpage>
            <pub-id pub-id-type="pmid">32617373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harcourt</surname>
                <given-names>BH</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Cohn</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>MacNeil</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Messonnier</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Mayer</surname>
                <given-names>LW</given-names>
              </name>
            </person-group>
            <article-title>Population-Based Surveillance of Neisseria meningitidis Antimicrobial Resistance in the United States.</article-title>
            <source>Open Forum Infect Dis</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>ofv117</fpage>
            <pub-id pub-id-type="pmid">26357666</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dunaway</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Maxwell</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Tantalo</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Sahi</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Marra</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Neurosyphilis Treatment Outcomes After Intravenous Penicillin G Versus Intramuscular Procaine Penicillin Plus Oral Probenecid.</article-title>
            <source>Clin Infect Dis</source>
            <year>2020</year>
            <month>Jul</month>
            <day>11</day>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>267</fpage>
            <page-range>267-273</page-range>
            <pub-id pub-id-type="pmid">31504293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gillam</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Turner</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics in the treatment of periodontal disease: a guide for the general dental practitioner.</article-title>
            <source>Prim Dent J</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>43</fpage>
            <page-range>43-7</page-range>
            <pub-id pub-id-type="pmid">25198638</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wyber</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Taubert</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Marko</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Benzathine Penicillin G for the Management of RHD: Concerns About Quality and Access, and Opportunities for Intervention and Improvement.</article-title>
            <source>Glob Heart</source>
            <year>2013</year>
            <month>Sep</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>227</fpage>
            <page-range>227-34</page-range>
            <pub-id pub-id-type="pmid">25690500</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention</collab>
            </person-group>
            <article-title>Sexually transmitted diseases treatment guidelines, 2015.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2015</year>
            <month>Jun</month>
            <day>05</day>
            <volume>64</volume>
            <issue>RR-03</issue>
            <fpage>1</fpage>
            <page-range>1-137</page-range>
            <pub-id pub-id-type="pmid">26042815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Mobashery</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Constructing and deconstructing the bacterial cell wall.</article-title>
            <source>Protein Sci</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>629</fpage>
            <page-range>629-646</page-range>
            <pub-id pub-id-type="pmid">31747090</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gordon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mouz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Du&#x000e9;e</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dideberg</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance.</article-title>
            <source>J Mol Biol</source>
            <year>2000</year>
            <month>Jun</month>
            <day>02</day>
            <volume>299</volume>
            <issue>2</issue>
            <fpage>477</fpage>
            <page-range>477-85</page-range>
            <pub-id pub-id-type="pmid">10860753</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Espinosa-Gongora</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jessen</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Kieler</surname>
                <given-names>IN</given-names>
              </name>
              <name>
                <surname>Damborg</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bj&#x000f8;rnvad</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Gudeta</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Pires Dos Santos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sablier-Gallis</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sayah-Jeanne</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Corbel</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nevi&#x000e8;re</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hugon</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Saint-Lu</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>de Gunzburg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guardabassi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Impact of oral amoxicillin and amoxicillin/clavulanic acid treatment on bacterial diversity and &#x003b2;-lactam resistance in the canine faecal microbiota.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2020</year>
            <month>Feb</month>
            <day>01</day>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>351</fpage>
            <page-range>351-361</page-range>
            <pub-id pub-id-type="pmid">31778166</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolman</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Gionfriddo</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Heindel</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Mukhija</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Witkowski</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bommareddy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vanwert</surname>
                <given-names>AL</given-names>
              </name>
            </person-group>
            <article-title>Organic anion transporter 3 interacts selectively with lipophilic &#x003b2;-lactam antibiotics.</article-title>
            <source>Drug Metab Dispos</source>
            <year>2013</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>791</fpage>
            <page-range>791-800</page-range>
            <pub-id pub-id-type="pmid">23344796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barker</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Germovsek</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sharland</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>What do I need to know about penicillin antibiotics?</article-title>
            <source>Arch Dis Child Educ Pract Ed</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>102</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-50</page-range>
            <pub-id pub-id-type="pmid">27412043</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wilson</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Arkell</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Riezk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gilchrist</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hope</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Holmes</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Rawson</surname>
                <given-names>TM</given-names>
              </name>
            </person-group>
            <article-title>Addition of probenecid to oral &#x003b2;-lactam antibiotics: a systematic review and meta-analysis.</article-title>
            <source>J Antimicrob Chemother</source>
            <year>2022</year>
            <month>Aug</month>
            <day>25</day>
            <volume>77</volume>
            <issue>9</issue>
            <fpage>2364</fpage>
            <page-range>2364-2372</page-range>
            <pub-id pub-id-type="pmid">35726853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Robbins</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McNamara</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Daly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Conway</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Effat</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Woo</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Sadayappan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rubinstein</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Probenecid Improves Cardiac Function in Patients With Heart Failure With Reduced Ejection Fraction In Vivo and Cardiomyocyte Calcium Sensitivity In Vitro.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2018</year>
            <month>Jan</month>
            <day>13</day>
            <volume>7</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29331959</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r18">
          <label>18</label>
          <element-citation publication-type="book">
            <chapter-title>Penicillins (1st Generation)</chapter-title>
            <source>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]</source>
            <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2020</year>
            <month>10</month>
            <day>20</day>
            <pub-id pub-id-type="pmid">31644108</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tunkel</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Hasbun</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhimraj</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Byers</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kaplan</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Scheld</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>van de Beek</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bleck</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Garton</surname>
                <given-names>HJL</given-names>
              </name>
              <name>
                <surname>Zunt</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.</article-title>
            <source>Clin Infect Dis</source>
            <year>2017</year>
            <month>Mar</month>
            <day>15</day>
            <volume>64</volume>
            <issue>6</issue>
            <fpage>e34</fpage>
            <page-range>e34-e65</page-range>
            <pub-id pub-id-type="pmid">28203777</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parker</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Karchmer</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Muhammad</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.</article-title>
            <source>Clin Infect Dis</source>
            <year>2022</year>
            <month>Oct</month>
            <day>17</day>
            <volume>75</volume>
            <issue>Suppl 3</issue>
            <fpage>S417</fpage>
            <page-range>S417-S431</page-range>
            <pub-id pub-id-type="pmid">36251549</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zoratti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Moretti</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rebuzzi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Albergati</surname>
                <given-names>IV</given-names>
              </name>
              <name>
                <surname>Di Somma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Decorti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Di Bella</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Croc&#x000e8;</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Giuffr&#x000e8;</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Antibiotics and Liver Cirrhosis: What the Physicians Need to Know.</article-title>
            <source>Antibiotics (Basel)</source>
            <year>2021</year>
            <month>Dec</month>
            <day>28</day>
            <volume>11</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">35052907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smyth</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Prescribing for patients on dialysis.</article-title>
            <source>Aust Prescr</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>39</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <page-range>21-4</page-range>
            <pub-id pub-id-type="pmid">27041803</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heikkil&#x000e4;</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Erkkola</surname>
                <given-names>RU</given-names>
              </name>
            </person-group>
            <article-title>The need for adjustment of dosage regimen of penicillin V during pregnancy.</article-title>
            <source>Obstet Gynecol</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>81</volume>
            <issue>6</issue>
            <fpage>919</fpage>
            <page-range>919-21</page-range>
            <pub-id pub-id-type="pmid">8497356</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <article-title>Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797.</article-title>
            <source>Obstet Gynecol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>135</volume>
            <issue>2</issue>
            <fpage>e51</fpage>
            <page-range>e51-e72</page-range>
            <pub-id pub-id-type="pmid">31977795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r25">
          <label>25</label>
          <element-citation publication-type="book">
            <chapter-title>Penicillin V</chapter-title>
            <source>Drugs and Lactation Database (LactMed&#x000ae;) [Internet]</source>
            <publisher-name>National Institute of Child Health and Human Development</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2021</year>
            <month>2</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">30000121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r26">
          <label>26</label>
          <element-citation publication-type="book">
            <chapter-title>Penicillin G</chapter-title>
            <source>Drugs and Lactation Database (LactMed&#x000ae;) [Internet]</source>
            <publisher-name>National Institute of Child Health and Human Development</publisher-name>
            <publisher-loc>Bethesda (MD)</publisher-loc>
            <year>2021</year>
            <month>2</month>
            <day>15</day>
            <pub-id pub-id-type="pmid">30000119</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdulkader</surname>
                <given-names>RCRM</given-names>
              </name>
              <name>
                <surname>Burdmann</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Lebr&#x000e3;o</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Duarte</surname>
                <given-names>YAO</given-names>
              </name>
              <name>
                <surname>Zanetta</surname>
                <given-names>DMT</given-names>
              </name>
            </person-group>
            <article-title>Aging and decreased glomerular filtration rate: An elderly population-based study.</article-title>
            <source>PLoS One</source>
            <year>2017</year>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>e0189935</fpage>
            <pub-id pub-id-type="pmid">29261774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The facts about penicillin allergy: a review.</article-title>
            <source>J Adv Pharm Technol Res</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>1</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <page-range>11-7</page-range>
            <pub-id pub-id-type="pmid">22247826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chow</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Hui</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Szeto</surname>
                <given-names>CC</given-names>
              </name>
            </person-group>
            <article-title>Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside.</article-title>
            <source>Eur J Clin Microbiol Infect Dis</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>24</volume>
            <issue>10</issue>
            <fpage>649</fpage>
            <page-range>649-53</page-range>
            <pub-id pub-id-type="pmid">16261307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r30">
          <label>30</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Finnigan</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Rout</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Leslie</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Bashir</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <chapter-title>Allergic and Drug-Induced Interstitial Nephritis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>9</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">29493948</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Belum</surname>
                <given-names>GR</given-names>
              </name>
              <name>
                <surname>Belum</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Chaitanya Arudra</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>BS</given-names>
              </name>
            </person-group>
            <article-title>The Jarisch-Herxheimer reaction: revisited.</article-title>
            <source>Travel Med Infect Dis</source>
            <year>2013</year>
            <season>Jul-Aug</season>
            <volume>11</volume>
            <issue>4</issue>
            <fpage>231</fpage>
            <page-range>231-7</page-range>
            <pub-id pub-id-type="pmid">23632012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gaig</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Paniagua</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>[Hoigne's syndrome].</article-title>
            <source>Allergol Immunopathol (Madr)</source>
            <year>2005</year>
            <season>Jan-Feb</season>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-8</page-range>
            <pub-id pub-id-type="pmid">15777526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McNulty</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Kuchi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Gunja</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Food-induced methemoglobinemia: A systematic review.</article-title>
            <source>J Food Sci</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>87</volume>
            <issue>4</issue>
            <fpage>1423</fpage>
            <page-range>1423-1448</page-range>
            <pub-id pub-id-type="pmid">35397145</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ocampo</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>L&#x000e1;z&#x000e1;r</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Papp</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Arnoldini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Abel zur Wiesch</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Busa-Fekete</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fekete</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>P&#x000e1;l</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ackermann</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bonhoeffer</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Antagonism between bacteriostatic and bactericidal antibiotics is prevalent.</article-title>
            <source>Antimicrob Agents Chemother</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>58</volume>
            <issue>8</issue>
            <fpage>4573</fpage>
            <page-range>4573-82</page-range>
            <pub-id pub-id-type="pmid">24867991</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ivanyuk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Livio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Biollaz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Buclin</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Renal Drug Transporters and Drug Interactions.</article-title>
            <source>Clin Pharmacokinet</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>825</fpage>
            <page-range>825-892</page-range>
            <pub-id pub-id-type="pmid">28210973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levison</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Levison</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics and pharmacodynamics of antibacterial agents.</article-title>
            <source>Infect Dis Clin North Am</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>4</issue>
            <fpage>791</fpage>
            <page-range>791-815, vii</page-range>
            <pub-id pub-id-type="pmid">19909885</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smits</surname>
                <given-names>WK</given-names>
              </name>
              <name>
                <surname>Lyras</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lacy</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Wilcox</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Kuijper</surname>
                <given-names>EJ</given-names>
              </name>
            </person-group>
            <article-title>Clostridium difficile infection.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2016</year>
            <month>Apr</month>
            <day>07</day>
            <volume>2</volume>
            <fpage>16020</fpage>
            <pub-id pub-id-type="pmid">27158839</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>&#x000d6;brink-Hansen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wiggers</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bibby</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Hardlei</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kragh Thomsen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brock</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Penicillin G Treatment in Infective Endocarditis Patients - Does Standard Dosing Result in Therapeutic Plasma Concentrations?</article-title>
            <source>Basic Clin Pharmacol Toxicol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>120</volume>
            <issue>2</issue>
            <fpage>179</fpage>
            <page-range>179-186</page-range>
            <pub-id pub-id-type="pmid">27565458</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>STEWART</surname>
                <given-names>GT</given-names>
              </name>
            </person-group>
            <article-title>TOXICITY OF THE PENICILLINS.</article-title>
            <source>Postgrad Med J</source>
            <year>1964</year>
            <month>Dec</month>
            <volume>40</volume>
            <issue>Suppl</issue>
            <fpage>SUPPL:160</fpage>
            <page-range>SUPPL:160-9</page-range>
            <pub-id pub-id-type="pmid">14246836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grill</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Maganti</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Neurotoxic effects associated with antibiotic use: management considerations.</article-title>
            <source>Br J Clin Pharmacol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>72</volume>
            <issue>3</issue>
            <fpage>381</fpage>
            <page-range>381-93</page-range>
            <pub-id pub-id-type="pmid">21501212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26891.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cusumano</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Defrank</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Funk</surname>
                <given-names>OG</given-names>
              </name>
              <name>
                <surname>Lerner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tanprayoon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vasa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mazo</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>The Role of an Infectious Diseases Faculty Pharmacist and Pharmacy Students on an Antimicrobial Stewardship Team at a Community Non-teaching Hospital.</article-title>
            <source>J Pharm Pract</source>
            <year>2024</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>2</issue>
            <fpage>335</fpage>
            <page-range>335-342</page-range>
            <pub-id pub-id-type="pmid">36263511</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
